BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8746201)

  • 1. Acute hypoxic pulmonary vasoconstriction in man is attenuated by type I angiotensin II receptor blockade.
    Kiely DG; Cargill RI; Lipworth BJ
    Cardiovasc Res; 1995 Dec; 30(6):875-80. PubMed ID: 8746201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale.
    Kiely DG; Cargill RI; Wheeldon NM; Coutie WJ; Lipworth BJ
    Cardiovasc Res; 1997 Jan; 33(1):201-8. PubMed ID: 9059545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor blockade and effects on pulmonary hemodynamics and hypoxic pulmonary vasoconstriction in humans.
    Kiely DG; Cargill RI; Lipworth BJ
    Chest; 1996 Sep; 110(3):698-703. PubMed ID: 8797414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of hypoxaemia and angiotensin II in the human pulmonary vascular bed.
    Cargill RI; Lipworth BJ
    Pulm Pharmacol; 1994 Oct; 7(5):305-10. PubMed ID: 7626917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
    Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers.
    Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
    Cardiovasc Res; 1996 Nov; 32(5):973-9. PubMed ID: 8944829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of frusemide and hypoxia on the pulmonary vascular bed in man.
    Kiely DG; Cargill RI; Lipworth BJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):309-13. PubMed ID: 9088586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans.
    Cargill RI; Lipworth BJ
    Br J Clin Pharmacol; 1995 Dec; 40(6):585-90. PubMed ID: 8703666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of angiotensin II in hemodynamic responses to dynamic exercise in miniswine.
    Stebbins CL; Symons JD
    J Appl Physiol (1985); 1995 Jan; 78(1):185-90. PubMed ID: 7713810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
    Cody RJ; Binkley PF; Haas GJ; Brown DM
    Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
    Hedelin P; Kylhammar D; Rådegran G
    Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats.
    Ferreira-do-Vale C; Renzi A; Camargo GP; Saad WA; Luiz AC; Menani JV; Silveira JE; Camargo LA
    Braz J Med Biol Res; 1995 Oct; 28(10):1097-101. PubMed ID: 8634683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats.
    Soltis EE; Jewell AL; Dwoskin LP; Cassis LA
    Clin Exp Hypertens; 1993 Jan; 15(1):171-84. PubMed ID: 8467311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of angiotensin II receptor-1 blockade in the hypoxic pulmonary vasoconstriction response in newborn piglets.
    Camelo JS; Hehre D; Devia C; Camelo SH; Bancalari E; Suguihara C
    Neonatology; 2008; 93(4):263-8. PubMed ID: 18043007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of pulsed-wave Doppler echocardiography to measure changes in MPAP. Is further validation required?
    Morrell NW
    Chest; 1997 May; 111(5):1469-70. PubMed ID: 9149625
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of responses to ANG IV: effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat.
    Nossaman BD; Feng CJ; Kaye AD; Kadowitz PJ
    Am J Physiol; 1995 Feb; 268(2 Pt 1):L302-8. PubMed ID: 7864150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin.
    Symons JD; Stebbins CL
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):223-31. PubMed ID: 8856477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
    MacFadyen RJ; Tree M; Lever AF; Reid JL
    Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
    Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary interactions of salbutamol and hypoxaemia in healthy young volunteers.
    Kiely DG; Cargill RI; Lipworth BJ
    Br J Clin Pharmacol; 1995 Oct; 40(4):313-8. PubMed ID: 8554932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.